Psilocybin
The Resurgence of Psychedelics: reMind’s 2nd Annual Psychedelics Business Forum
On November 28-29, 2023, join us for reMind’s 2nd annual Psychedelic Business Forum at the illustrious Westgate Las Vegas Resort & Casino.
The realm of psychedelic medicine is undergoing a profound evolution. As the winds of change sweep across states and advocacy groups, novel approaches to mental well-being and groundbreaking treatments are on the horizon. One platform leading the conversation and catalyzing change is reMind, and it’s gearing up to make its second annual statement in the heart of Las Vegas.
Unveiling The Psychedelics Business Forum
On November 28-29, 2023, the illustrious Westgate Las Vegas Resort & Casino will be adorned with thought leaders, innovators, and pioneers of the psychedelics industry. The reMind Psychedelics Business Forum, in a riveting collaboration with MJBizCon, promises to be a nexus of knowledge and opportunity, linking communities with a shared vision.
For those who champion the responsible growth of the psychedelic business and its potential for holistic healing, this event is an invitation to explore, learn, and connect. The advent of state-regulated markets in Oregon and Colorado signals a monumental shift in the perception and acceptance of psychedelics. As Sara Vaughn, the VP Brand Leader of reMind, rightly points out, the industry is at a “historic inflection point.” And as momentum gathers in various states, the forum emerges as a crucible for shaping the future of this budding domain.
Behind the curtains of this enthralling event is Emerald, an organization known for its knack for creating impactful experiences. Emerald’s prowess in blending in-person and digital platforms offers businesses an edge, ensuring they remain at the forefront of their industries.
The reMind platform doesn’t just restrict its offerings to in-person events. With a suite of digital products available on their website, enthusiasts can access a wealth of information, from special reports and webinars to the latest news on psychedelic legislation and research.
A Glimpse into the Forum’s Offerings
Who is Today’s Psychedelic Consumer? A Deep Dive Into the Data and Trends. From generational attitudes and usage habits to geographical analysis, get an in-depth look at the trends that are shaping the rapidly evolving psychedelics industry.
Functional Mushrooms, Microdosing, and Brain Health: The Latest Research and Trends. Industry experts separate the facts from fiction in the much-hyped world of botanicals, adaptogens, nootropics and microdosing. Discover what legal business opportunities currently exist, what the competitive landscape looks like, and how to prepare for new opportunities as policies change.
How the Cannabis Industry Can Get Involved: Opportunities in Psychedelics Abound. Whether mushroom cultivation, retail sale of functionals, or expanding into healing services with cannabis-assisted therapy, established businesses in the cannabis industry have many doorways into the emerging psychedelics marketplace. Get insights, advice and ideas on how to take your organization in new directions.
Policy Updates and Forecasts: State-Level Initiatives and FDA Approval Pipelines. As dozens of states pursue psychedelic policy reforms, we take a closer look into the many pathways to legalization — from grassroots advocacy and ballot measures to direct legislation and executive orders — and how the business community can help drive reform. Also: The latest forecasts on expected FDA approvals of MDMA and psilocybin.
Set Up Your Business for Success: Insider Advice on Taxes, Banking, Marketing and More. Legal and financial experts with deep experience in the space share their insights on how to establish and operate a psychedelic company, including pros and cons of different banking practices, branding strategies, and business structures (LLCs, Public Benefit Corps, nonprofits, etc.).
A Call to Join the Psychedelic Revolution
The reMind Psychedelics Business Forum is more than just an event; it’s a clarion call for those passionate about the realm of psychedelics. It’s a summons to be part of a transformative journey, one that promises to redefine well-being and healing for generations to come. For those ready to embrace this new era, Las Vegas awaits.
For those interested in participating or learning more, registration is now open. And if you missed out on the magic of the 2022 reMind Psychedelics Business Forum, session recordings are available for viewing.
psilocybin fda research legalization psychedelics psychedelic mdma-
Law & Regulation1 week ago
FDA to weigh safety, impact of MDMA therapy for PTSD at June meeting
-
Psychedelics1 week ago
Numinus Wellness Focused on Boosting Profitability and Expanding Community Support
-
Psychedelics1 week ago
MindMed Reports First Quarter 2024 Financial Results and Business Updates
-
Psychedelics1 week ago
Optimi Health Receives Export Permit from Health Canada to Ship MDMA To Tel Aviv University’s Institute for Psychedelic Research
-
Psilocybin1 week ago
Oregon authorities give Kaya Holdings license for psilocybin treatment clinic
-
Law & Regulation1 week ago
Compass Pathways keeps plugging away with its psilocybin study trials
-
Ketamine1 week ago
Clinical-Stage BioTech Drug Stocks Portfolio UP 7% In w/e May 3rd
-
Psychedelics1 week ago
Optimi Health Provides Corporate Update